Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma

被引：0

作者：

Driver, Brandon

Miller, Ross A.

Deavers, Michael

Tacha, David

Bernicker, Eric

Cagle, Philip T.

机构：

[1] Houston Methodist Hosp, Houston, TX USA

[2] Biocare Med LLC, Concord, CA USA

来源：

LABORATORY INVESTIGATION | 2017年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1913

引用

页码：475A / 475A

页数：1

共 50 条

[41] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
Savant, Deepika
Vitkovski, Taisia
Thomas, Rebecca
Rishi, Arvind
LABORATORY INVESTIGATION, 2017, 97 : 199A - 199A
[42] Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
Mino-Kenudson, Mari
CANCER BIOLOGY & MEDICINE, 2016, 13 (02) : 157 - 170
[43] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
Yu Wei-Bo
Rao Jian-Yu
慢性疾病与转化医学（英文）, 2019, 5 (03) : 170 - 177
[44] Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
Alexandra Giatromanolaki
Ioannis M. Koukourakis
Konstantina Balaska
Achilleas G. Mitrakas
Adrian L. Harris
Michael I. Koukourakis
Medical Oncology, 2019, 36
[45] Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer
Liu, K. H.
Yang, W.
Tian, H. P.
CLINICAL RADIOLOGY, 2024, 79 (02) : 264 - 272
[46] Programmed cell death ligand-1(PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
Mari Mino-Kenudson
Cancer Biology & Medicine, 2016, 13 (02) : 157 - 170
[47] Programmed cell death ligand-1(PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
Mari Mino-Kenudson
Cancer Biology & Medicine, 2016, (02) : 157 - 170
[48] Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
Paydas, Semra
Bagir, Emine
Seydaoglu, Gulsah
Ercolak, Vehbi
Ergin, Melek
ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1545 - 1552
[49] Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
Giatromanolaki, Alexandra
Koukourakis, Ioannis M.
Balaska, Konstantina
Mitrakas, Achilleas G.
Harris, Adrian L.
Koukourakis, Michael I.
MEDICAL ONCOLOGY, 2019, 36 (09)
[50] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
Peng, Nanqiu
Qin, Liang
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5

← 1 2 3 4 5 →